Floatz logo

Dp-B99

Brain Ischemia

D-Pharm Ltd.Phase 2Dormant
CCC
55/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
40/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Brain Ischemia cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
City Clinical Hospital No. 67, Moscow, Russia
Phase 4BB
Dipyridamole
UMC Utrecht
Phase 4BB
Sovateltide
Pharmazz, Inc.
Phase 3BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Asan Medical Center
Phase 4BB
3-N-BUTYLPHTHALIDE
Qianfoshan Hospital
Phase 4BB

View all 36 →

Same molecule, other indications

Dp-B99 is also rated in:

cerebrovascular disorderDormant
CCC
Indicative ·
55 / 100
View asset →
ischemic strokeDormant
CCC
Indicative ·
50 / 100
View asset →
stroke disorderDormant
CCC
Indicative ·
49 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →